Danahy Kevin Patrick, Chief Commercial Officer at Pulse Biosciences Inc. ($PLSE), sold about $3.4 million worth of shares through 10 open market transactions over the last 365 days. His most recent sale occurred on February 18, 2026. These sales rank 2,499th among 11,678 individual insiders in our database, where the average is about $8.6 million across roughly 6.4 transactions. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Stock Option (right to buy) | 5000 | $0.00 | 300,000.0000 | 67,989,078 | 1.64% | 0.01% |
| Feb. 18, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | S | Common Stock | 5000 | $23.64 | 43,298.0000 | 67,989,078 | 10.35% | 0.01% |
| Feb. 18, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Common Stock | 5000 | $1.53 | 48,298.0000 | 67,989,078 | 11.55% | 0.01% |
| Feb. 17, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Stock Option (right to buy) | 20000 | $0.00 | 305,000.0000 | 67,989,078 | 6.15% | 0.03% |
| Feb. 12, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Common Stock | 20000 | $1.53 | 63,298.0000 | 67,767,578 | 46.19% | 0.03% |
| Feb. 13, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Stock Option (right to buy) | 20000 | $0.00 | 325,000.0000 | 67,767,578 | 5.80% | 0.03% |
| Feb. 12, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Stock Option (right to buy) | 20000 | $0.00 | 345,000.0000 | 67,767,578 | 5.48% | 0.03% |
| Feb. 17, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | S | Common Stock | 20000 | $23.63 | 43,298.0000 | 67,989,078 | 31.60% | 0.03% |
| Feb. 17, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Common Stock | 20000 | $1.53 | 63,298.0000 | 67,989,078 | 46.19% | 0.03% |
| Feb. 13, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | S | Common Stock | 20000 | $23.53 | 43,298.0000 | 67,767,578 | 31.60% | 0.03% |
| Feb. 13, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Common Stock | 20000 | $1.53 | 63,298.0000 | 67,767,578 | 46.19% | 0.03% |
| Feb. 12, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | S | Common Stock | 20000 | $23.37 | 43,298.0000 | 67,767,578 | 31.60% | 0.03% |
| Feb. 11, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Common Stock | 20000 | $1.53 | 63,298.0000 | 67,767,578 | 46.19% | 0.03% |
| Feb. 9, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Common Stock | 20000 | $1.53 | 63,298.0000 | 67,767,578 | 46.19% | 0.03% |
| Feb. 9, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | S | Common Stock | 20000 | $21.45 | 43,298.0000 | 67,767,578 | 31.60% | 0.03% |
| Feb. 10, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Common Stock | 20000 | $1.53 | 63,298.0000 | 67,767,578 | 46.19% | 0.03% |
| Feb. 10, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | S | Common Stock | 20000 | $23.52 | 43,298.0000 | 67,767,578 | 31.60% | 0.03% |
| Feb. 11, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | S | Common Stock | 20000 | $25.20 | 43,298.0000 | 67,767,578 | 31.60% | 0.03% |
| Feb. 9, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Stock Option (right to buy) | 20000 | $0.00 | 405,000.0000 | 67,767,578 | 4.71% | 0.03% |
| Feb. 10, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Stock Option (right to buy) | 20000 | $0.00 | 385,000.0000 | 67,767,578 | 4.94% | 0.03% |
| Feb. 11, 2026 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Stock Option (right to buy) | 20000 | $0.00 | 365,000.0000 | 67,767,578 | 5.19% | 0.03% |
| Oct. 2, 2025 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Common Stock | 4600 | $1.53 | 47,898.0000 | 67,273,800 | 10.62% | 0.01% |
| Oct. 2, 2025 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Stock Option (right to buy) | 4600 | $0.00 | 425,000.0000 | 67,273,800 | 1.07% | 0.01% |
| Oct. 2, 2025 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | S | Common Stock | 4600 | $18.53 | 43,298.0000 | 67,273,800 | 9.60% | 0.01% |
| Sept. 19, 2025 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | S | Common Stock | 400 | $18.48 | 43,298.0000 | 67,273,800 | 0.92% | 0.00% |
| Sept. 19, 2025 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Common Stock | 400 | $1.53 | 43,698.0000 | 67,273,800 | 0.92% | 0.00% |
| Sept. 18, 2025 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Common Stock | 20000 | $1.53 | 63,298.0000 | 67,273,800 | 46.19% | 0.03% |
| Sept. 18, 2025 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | S | Common Stock | 20000 | $18.49 | 43,298.0000 | 67,273,800 | 31.60% | 0.03% |
| Sept. 19, 2025 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Stock Option (right to buy) | 400 | $0.00 | 429,600.0000 | 67,273,800 | 0.09% | 0.00% |
| Sept. 18, 2025 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | M | Stock Option (right to buy) | 20000 | $0.00 | 430,000.0000 | 67,273,800 | 4.44% | 0.03% |
| July 3, 2024 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | P | Warrant (right to buy) | 325 | $0.00 | 325.0000 | 0 | 9999.99% | 0.00% |
| July 3, 2024 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | P | Warrant (right to buy) | 325 | $0.00 | 325.0000 | 0 | 9999.99% | 0.00% |
| July 3, 2024 | PULSE BIOSCIENCES, INC. | $PLSE | Danahy Kevin Patrick | Chief Commercial Officer | X | Common Stock | 650 | $0.00 | 36,537.0000 | 0 | 1.81% | 0.00% |